Daily Anesthesiology Research Analysis
Three perioperative/critical-care studies stand out today: a prospective registry analysis shows earlier polymyxin B hemoperfusion improves short-term hemodynamics in high-dose norepinephrine septic shock; a prospective mHealth study identifies early recovery phenotypes after spine surgery that predict 12‑month outcomes; and a multi‑society consensus provides time‑critical (first hour) recommendations for intracerebral hemorrhage management.
Summary
Three perioperative/critical-care studies stand out today: a prospective registry analysis shows earlier polymyxin B hemoperfusion improves short-term hemodynamics in high-dose norepinephrine septic shock; a prospective mHealth study identifies early recovery phenotypes after spine surgery that predict 12‑month outcomes; and a multi‑society consensus provides time‑critical (first hour) recommendations for intracerebral hemorrhage management.
Research Themes
- Precision timing in critical-care interventions
- Digital phenotyping of postoperative recovery
- Standardized early neurocritical care pathways
Selected Articles
1. Multidomain postoperative recovery trajectories after lumbar and thoracolumbar spine surgery.
In a prospective cohort of 129 patients undergoing lumbar/thoracolumbar surgery, daily ecological momentary assessments and wearable activity metrics during the first postoperative month clustered into two dominant recovery patterns across domains. Favorable early recovery in pain and steps/min predicted greater 12‑month improvements in disability and function, whereas less favorable pain recovery was linked to higher complication rates (23% vs 7%). Multidomain favorable recovery outperformed traditional assessments in prognostic value.
Impact: Introduces scalable mHealth phenotyping that links early postoperative trajectories to 12‑month outcomes, offering a pathway to personalize rehabilitation and resource allocation.
Clinical Implications: Incorporate early postoperative EMA and wearable monitoring to stratify risk and tailor rehabilitation; patients with unfavorable early pain trajectories may benefit from intensified follow-up and interventions.
Key Findings
- Two dominant early recovery patterns were identified across pain, depression, and activity domains using EMA and Fitbit data.
- Favorable early recovery in pain intensity and steps/min was associated with greater 12‑month improvements in disability and physical function.
- Patients with less favorable pain recovery had higher complication rates (23% vs 7%).
- Aggregating favorable domains improved prognostic performance beyond traditional assessments.
Methodological Strengths
- Prospective design with daily ecological momentary assessment and objective wearable metrics
- Multidomain clustering via functional principal component analysis with 12‑month outcomes
Limitations
- Single-center cohort with modest sample size (n=129), limiting generalizability
- Observational design precludes causal inference; potential residual confounding
Future Directions: External validation across diverse health systems and randomized trials testing mHealth-guided rehabilitation pathways to improve outcomes.
BACKGROUND CONTEXT: Understanding early postoperative recovery is crucial for improving perioperative care and long-term outcomes. Traditional recovery assessments relying primarily on cross-sectional patient-reported measures may not fully capture the complexity of the recovery process. PURPOSE: Our study evaluates early postoperative recovery using mobile health assessment and explores the relationship between early recovery patterns, multidomain recovery, and long-term outcomes. STUDY DESIGN/SETTING: A prospective observational study.
2. Time to administer polymyxin B hemoperfusion and hemodynamics in patients with septic shock requiring high-dose norepinephrine: a predetermined analysis of a prospective cohort study.
Among 82 PMX-HP–treated patients with septic shock on high-dose norepinephrine, earlier initiation (median 265 min from ICU admission) was associated with higher mean arterial pressure at 6–8 h and lower vasoactive-inotropic score from 8 h onward. Early use yielded more vasopressor/inotrope-free days (median 23 vs 21; p=0.027) and ICU-free days (18 vs 14; p=0.025); 90‑day mortality trended lower (15.3% vs 31.3%; adjusted HR 0.38, 95% CI 0.13–1.09).
Impact: Addresses the time-sensitivity of PMX-hemoperfusion in refractory septic shock with real-world prospective data, informing protocolized timing of an extracorporeal therapy.
Clinical Implications: Consider earlier PMX-HP initiation in high-dose norepinephrine septic shock to improve short-term hemodynamics and potentially clinical course; incorporate timing into ICU sepsis bundles while awaiting randomized trials.
Key Findings
- Early PMX-HP (vs late) achieved higher mean arterial pressure at 6–8 h and lower VIS from 8 h onward within 48 h.
- More vasopressor/inotrope-free days (median 23 vs 21; p=0.027) and ICU-free days (18 vs 14; p=0.025) with early initiation.
- Lower 90-day mortality trend with early PMX-HP (15.3% vs 31.3%; adjusted HR 0.38, 95% CI 0.13–1.09), though not statistically significant.
Methodological Strengths
- Predetermined analysis of a prospective multicenter registry with standardized hemodynamic endpoints
- Multivariable adjustment with time-to-event analysis and registered protocol
Limitations
- Nonrandomized cohort with potential residual confounding and selection bias
- Sample limited to PMX-HP–treated subset (n=82), affecting power and generalizability
Future Directions: Randomized trials to test early vs delayed PMX-HP and enrichment strategies to identify responsive phenotypes.
BACKGROUND: Delayed administration of polymyxin B hemoperfusion (PMX-HP) for septic shock could diminish its efficacy in real-world clinical settings. METHODS: BEAT-SHOCK registry is a prospective registry consisting of 309 adult patients with septic shock requiring high-dose norepinephrine (≥ 0.2 μg/kg/min). This predetermined analysis included 82 patients treated with PMX-HP. They were grouped according to the median time from ICU admission to administration of PMX-HP: the early administration group (n = 40) and the late administration group (n = 42).
3. Golden hour management in the patient with intraparenchymal cerebral hemorrhage: an Italian intersociety document.
A multidisciplinary, intersocietal consensus synthesizing literature (PRISMA-guided) and expert Delphi prioritizes the first-hour management of ICH. Key recommendations include early CT angiography, risk stratification with the ICH score, strict blood pressure control (target 130–140 mmHg) using alpha- and beta-blockers while avoiding hypotension, intubation for impaired consciousness, seizure treatment (not prophylaxis), appropriate anticoagulant reversal (e.g., PCC), and regionalization to ICU/neurosurgical centers.
Impact: Provides actionable, time-critical recommendations across systems of care, aligning with AHA guidance and addressing heterogeneity in early ICH management, particularly for peripheral hospitals.
Clinical Implications: Adopt protocols prioritizing early CTA, targeted BP control (130–140 mmHg), airway protection for reduced consciousness, selective anticonvulsant use, rapid anticoagulant reversal, and triage to neurocritical care centers.
Key Findings
- CT angiography has >90% sensitivity/specificity to detect macrovascular lesions and active bleeding and is recommended early.
- Target systolic BP/mean arterial pressure with a goal of 130–140 mmHg using alpha- and beta-blockers while avoiding hypotension.
- Use ICH scores for risk stratification; intubate patients with impaired consciousness; treat seizures but avoid routine prophylaxis.
- Reverse anticoagulation promptly (e.g., PCC) in anticoagulant-related ICH; centralize severe cases to ICU/neurosurgical centers.
Methodological Strengths
- Systematic literature review (PRISMA 2020) combined with modified Delphi and UCLA-RAND appropriateness methodology
- Multidisciplinary, intersocietal consensus with external peer review
Limitations
- Many recommendations are consensus-based due to limited high-quality randomized evidence
- Uncertainty remains regarding long-term outcomes of certain interventions (e.g., PCC reversal)
Future Directions: Implementation studies and pragmatic trials to evaluate first-hour ICH bundles, optimal antihypertensive strategies, and indications for airway management and seizure therapy.
BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) accounts for 9-27% of all strokes worldwide and is associated with high mortality and disability. The main causes include vascular malformations, small- and large-vessel angiopathies, and coagulation disorders. Mortality rates reach approximately 40% at 1 month and 54% at 1 year, largely influenced by early management decisions. Rapid intervention, particularly within the first hour, is crucial, especially for patients initially treated in peripheral hospitals.